Consequently, assertions that NET burden scales directly with hyperandrogenemia or insulin resistance in PCOS should be presented as plausible but not yet definitively proven
Decision board Is BPC-157 the right page to act on
Katsuda Y, Kenmochi Y, Maki M, Sano R, Toriniwa Y, Ishii Y, Miyajima K, Kakimoto K, Ohta T
While the trials reported minimal injection site issues, proper technique remains important for safety
Likewise, BPC 157 therapy was shown in counteracting rapid clot formation in the portal vein, superior mesenteric vein, splenic vein, inferior vena cava, hepatic artery, and coronary artery, as well as peaked P waves, significant ST-elevation, tachycardia, gross organ lesions, and liver and spleen weight increases
Metallo, C